Skip to content

Clinical trials

Disorders of Excessive Somnolence trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Disorders of Excessive Somnolence Country / region: United States Clear all

99 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20033
20045
20052
20062
20072
20083
20095
20105
20112
20123
20131
20141
20163
20175
20182
20196
20206
20218
20223
20233
202411
20255
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed67
Recruiting14
Terminated8
Withdrawn4
Active, not recruiting3
Not yet recruiting1
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cephalon9
Axsome Therapeutics, Inc.7
Alkermes, Inc.6
Harmony Biosciences Management, Inc.4
Northwestern University4
Centessa Pharmaceuticals (UK) Limited3
Duke University3
Jazz Pharmaceuticals3
Massachusetts General Hospital3
University of Pennsylvania3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Disorders of Excessive Somnolence99
Narcolepsy29
Sleep Apnea, Obstructive16
Sleep Wake Disorders16
Sleep Initiation and Maintenance Disorders13
Idiopathic Hypersomnia12
Cataplexy11
Sleep Disorders, Circadian Rhythm8
Parkinson Disease7
Fatigue6

Trials

Showing 1 to 25 of 99. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.